Terms: = Cervical cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Clinical Outcome
22 results:
1. Comprehensive analysis of novel prognosis-related proteomic signature effectively improve risk stratification and precision treatment for patients with cervical cancer.
Ji X; Chu G; Chen Y; Jiao J; Lv T; Yao Q
Arch Gynecol Obstet; 2023 Mar; 307(3):903-917. PubMed ID: 35713693
[TBL] [Abstract] [Full Text] [Related]
2. Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers.
Kong B; Han CY; Kim SI; Patten DA; Han Y; Carmona E; Shieh DB; Cheung AC; Mes-Masson AM; Harper ME; Song YS; Tsang BK
J Ovarian Res; 2022 Jun; 15(1):70. PubMed ID: 35668443
[TBL] [Abstract] [Full Text] [Related]
3. Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer.
Choi CH; Chung JY; Kang JH; Paik ES; Lee YY; Park W; Byeon SJ; Chung EJ; Kim BG; Hewitt SM; Bae DS
Gynecol Oncol; 2020 May; 157(2):437-443. PubMed ID: 32107047
[TBL] [Abstract] [Full Text] [Related]
4. Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 cervical cancer with Negative Lymph Nodes.
Wang R; Tao X; Wu X; Jiang H; Xia H
J Minim Invasive Gynecol; 2020; 27(4):946-952. PubMed ID: 31394263
[TBL] [Abstract] [Full Text] [Related]
5. bcl-2, in combination with MVP and IGF-1R expression, improves prediction of clinical outcome in complete response cervical carcinoma patients treated by radiochemotherapy.
Henríquez-Hernández LA; Lloret M; Pinar B; Bordón E; Rey A; Lubrano A; Lara PC
Gynecol Oncol; 2011 Sep; 122(3):585-9. PubMed ID: 21708403
[TBL] [Abstract] [Full Text] [Related]
6. Overexpression of phosphorylated 4E-BP1 predicts for tumor recurrence and reduced survival in cervical carcinoma treated with postoperative radiotherapy.
Benavente S; Vergés R; Hermosilla E; Fumanal V; Casanova N; García A; Ramón Y Cajal S; Giralt J
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1316-22. PubMed ID: 19362787
[TBL] [Abstract] [Full Text] [Related]
7. bcl-2, p53 and HLA-DR antigen expression in surgically treated parotid cancer patients.
Genetzakis M; Gomatos IP; Georgiou AN; Giotakis J; Manolopoulos L; Papadimitriou K; Chra H; Leandros E; Tsigris C; Ferekidis EA
Eur Arch Otorhinolaryngol; 2009 Mar; 266(3):417-24. PubMed ID: 18584190
[TBL] [Abstract] [Full Text] [Related]
8. Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma.
Manavi M; Hudelist G; Fink-Retter A; Gschwandtler-Kaulich D; Pischinger K; Czerwenka K
Gynecol Oncol; 2007 May; 105(2):418-26. PubMed ID: 17306351
[TBL] [Abstract] [Full Text] [Related]
9. cDNA array analysis of cytobrush-collected normal and malignant cervical epithelial cells: a feasibility study.
Hudelist G; Czerwenka K; Singer C; Pischinger K; Kubista E; Manavi M
Cancer Genet Cytogenet; 2005 Apr; 158(1):35-42. PubMed ID: 15771902
[TBL] [Abstract] [Full Text] [Related]
10. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586
[TBL] [Abstract] [Full Text] [Related]
11. Relation between HPV-DNA and expression of p53, bcl-2, p21WAF-1, MIB-1, HER-2/neu and DNA ploidy in early cervical carcinoma: correlation with clinical outcome.
Graflund M; Sorbe B; Sigurdardóttir S; Karlsson MG
Oncol Rep; 2004 Jul; 12(1):169-76. PubMed ID: 15201979
[TBL] [Abstract] [Full Text] [Related]
12. Microinvasive squamous cell carcinoma of the cervix: immunohistochemically detected prognostic factors in a case with poor clinical outcome.
Kohlberger P; Edwards L; Hacker NF
Gynecol Oncol; 2003 Aug; 90(2):443-5. PubMed ID: 12893215
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of p53 and bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy.
Jain D; Srinivasan R; Patel FD; Kumari Gupta S
Gynecol Oncol; 2003 Jan; 88(1):22-8. PubMed ID: 12504622
[TBL] [Abstract] [Full Text] [Related]
14. Immunohistochemical expression of p53, bcl-2, and p21(WAF1/CIP1) in early cervical carcinoma: correlation with clinical outcome.
Graflund M; Sorbe B; Karlsson M
Int J Gynecol Cancer; 2002; 12(3):290-8. PubMed ID: 12060451
[TBL] [Abstract] [Full Text] [Related]
15. MIB-1, p53, bcl-2, and WAF-1 expression in pelvic lymph nodes and primary tumors in early stage cervical carcinomas: correlation with clinical outcome.
Graflund M; Sorbe B; Karlsson M
Int J Oncol; 2002 May; 20(5):1041-7. PubMed ID: 11956602
[TBL] [Abstract] [Full Text] [Related]
16. DNA ploidy correlates with grade, proliferation and clinical outcome but not with presence of human oncogenic HPVs or expression of bcl-2 in preneoplastic and neoplastic lesions of the uterine cervix.
Riháková P; Brychtová S; Kotrsová L; Pilka R; Kolár Z
Neoplasma; 2001; 48(4):274-7. PubMed ID: 11712678
[TBL] [Abstract] [Full Text] [Related]
17. The importance of biological factors (bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancer.
Tjalma WA; Weyler JJ; Bogers JJ; Pollefliet C; Baay M; Goovaerts GC; Vermorken JB; van Dam PA; van Marck EA; Buytaert PM
Eur J Obstet Gynecol Reprod Biol; 2001 Aug; 97(2):223-30. PubMed ID: 11451553
[TBL] [Abstract] [Full Text] [Related]
18. bcl-2, bax, bcl-x(L) and bcl-x(S) expression in neoplastic and normal cervical tissue.
Ferrandina G; Mozzetti S; Marone M; Fagotti A; Macchia G; Mancuso S; Scambia G
Cancer Lett; 2000 Jul; 155(1):19-27. PubMed ID: 10814875
[TBL] [Abstract] [Full Text] [Related]
19. Detection and typing of human papillomavirus in cervical carcinomas in Russian women: a prognostic study.
van Muyden RC; ter Harmsel BW; Smedts FM; Hermans J; Kuijpers JC; Raikhlin NT; Petrov S; Lebedev A; Ramaekers FC; Trimbos JB; Kleter B; Quint WG
Cancer; 1999 May; 85(9):2011-6. PubMed ID: 10223243
[TBL] [Abstract] [Full Text] [Related]
20. bcl-2 immunoreactivity but not p53 accumulation associated with tumour response to radiotherapy in cervical carcinoma.
Pillai MR; Jayaprakash PG; Nair MK
J Cancer Res Clin Oncol; 1999; 125(1):55-60. PubMed ID: 10037278
[TBL] [Abstract] [Full Text] [Related]
[Next]
